TI
ZVRA icon

Tidal Investments’s Zevra Therapeutics ZVRA Stock Holding History

Tidal Investments’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$150K Buy
+10,458
New +$116K ﹤0.01% 2503

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tidal Investments's ZVRA Position: Q2 2026 in Review

Tidal Investments opened a new position in Zevra Therapeutics (ZVRA) in Q2 2026: 10,458 shares worth $150K. The stake represents ﹤0.01% of the portfolio and ranks #2503 among its holdings.

157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • Tidal Investments held 10,458 shares of Zevra Therapeutics worth $150K as of Q2 2026.
  • Zevra Therapeutics was a new Tidal Investments position in Q2 2026.
  • Zevra Therapeutics made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #2503 holding.
  • 157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.